Rusan’s API plant in Ankleshwar receives USFDA GMP approval
Rusan Pharma plans to expand its portfolio with additional APIs, including Apomorphine, Buprenorphine, Naloxone, Naltrexone,…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.